Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease.

Anand, Santosh; Azam Ansari, Mohammad; Kumaraswamy Sukrutha, Sambamurthy; Alomary, Mohammad N; Anwar Khan, Anmar; Elderdery, Abozer Y

Anand, Santosh; Azam Ansari, Mohammad; Kumaraswamy Sukrutha, Sambamurthy; Alomary, Mohammad N; Anwar Khan, Anmar; Elderdery, Abozer Y.

Affiliation

Anand S; Department of Biotechnology, School of Applied Sciences, REVA University, Bengaluru, Karnataka, India.
Azam Ansari M; Department of Epidemic Disease Research, Institutes for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia. Electronic address: maansari@iau.edu.sa.
Kumaraswamy Sukrutha S; Department of Microbiology, Biotechnology and Food Technology, Jnana Bharathi Campus, Bangalore University, Bengaluru, Karnataka, India.
Alomary MN; National Centre for Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.
Anwar Khan A; Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Elderdery AY; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Saudi Arabia.

Neuroscience ; 507: 139-148, 2022 12 15.

Article de En | MEDLINE | ID: mdl-36372297

Sujet(s)
Mots clés

Alzheimer's disease; Parkinson's disease; arachidonic acid; lipid mediators; resolvins

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson / Maladie d'Alzheimer Type d'étude: Systematic_reviews Limites: Humans Langue: En Journal: Neuroscience Année: 2022 Type de document: Article Pays d'affiliation: Inde

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google